TRIAL EVALUATING 3-YEAR DISEASE FREE SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER TREATED WITH CHEMORADIATION PLUS INDUCTION OR CONSOLIDATION CHEMOTHERAPY AND TOTAL MESORECTAL EXCISION OR NON-OPERATIVE MANAGEMENT: